trump glp 1 deal unveils to expand coverage and lower costs on obesity drugs The Trump administration announced deals

Adhere to a low-fat, low-carbohydrate diet, with your last meal consumed no later than two hours before bedtime

Libido decline: PT-141 (Bremelanotide) is the only FDA-approved option in this list, approved specifically for hypoactive sexual desire disorder

A growing array of treatment modalities and new entrants are crowding the market, with biotech companies promoting next-generation GLP-1 candidates alongside established pharmaceutical players

They are not FDA-approved for medical, diagnostic, or therapeutic purposes

Safety Profile and Possible Side Effects Preclinical studies show BPC-157 was well-tolerated with no serious toxicity in mice, rats, rabbits, and dogs